Multi4 Medical Receives CE Mark for Bladder Cancer Treatment
Multi4 Medical has received CE mark approval for its Multi4 System, an innovative all-in-one technology that allows for bladder cancer treatment during the same outpatient visit where cancer is detected. This system eliminates the need for operating room procedures, general anesthesia, and hospitalization, enabling urologists to perform the treatment endoscopically while the patient is awake.
The Swedish MedTech company Multi4 Medical has received CE mark approval for the Multi4 System – a groundbreaking all-in-one technology that enables bladder cancer treatment during the same outpatient visit when cancer is detected, without operating room, anesthesia, or hospitalization….